Centiva Capital’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,106
Closed -$367K 1637
2024
Q3
$367K Buy
+13,106
New +$349K 0.01% 1453
2021
Q3
Sell
-22,391
Closed -$549K 1251
2021
Q2
$549K Buy
+22,391
New +$498K 0.01% 793
2019
Q4
Sell
-24,748
Closed -$483K 798
2019
Q3
$483K Buy
24,748
+14,084
+132% +$306K 0.03% 337
2019
Q2
$240K Buy
+10,664
New +$292K 0.01% 319

Other funds holding ALKS

Centiva Capital's ALKS Position: Q4 2024 in Review

Centiva Capital sold out of Alkermes (ALKS) in Q4 2024, closing a stake of 13,106 shares — an estimated $367K sold.

Centiva Capital first reported a position in ALKS in Q2 2019 and held it in 4 quarters. The position peaked at $549K in Q2 2021. 343 funds tracked by Wall St. Rank hold ALKS as of Q4 2024.

  • Centiva Capital reported no remaining Alkermes position as of Q4 2024 after selling out during the quarter.
  • Centiva Capital sold 13,106 Alkermes shares in Q4 2024, an estimated $367K.
  • Centiva Capital first reported a position in Alkermes in Q2 2019 and held it in 4 quarters.
  • Centiva Capital's Alkermes position peaked at $549K in Q2 2021.
  • 343 funds tracked by Wall St. Rank held Alkermes as of Q4 2024.

Based on Centiva Capital's 13F filing for Q4 2024, filed 14 Feb 2025.